AXIM Biotechnologies, Inc.
AXIM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,512 | -$8,060 | -$6,243 | -$16,032 |
| Dep. & Amort. | $432 | $427 | $426 | $2,116 |
| Deferred Tax | $0 | $0 | $0 | $7,545 |
| Stock-Based Comp. | $0 | $198 | $1,107 | $1,144 |
| Change in WC | $783 | $1,292 | $1,039 | -$28 |
| Other Non-Cash | $1,442 | $5,112 | $1,626 | $2,769 |
| Operating Cash Flow | -$855 | -$1,031 | -$2,044 | -$2,487 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | $0 | -$9 | -$50 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$9 | -$10 |
| Investing Cash Flow | -$3 | $0 | -$9 | -$50 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $480 | $675 | -$8 | $890 |
| Stock Issued | $222 | $491 | $1,742 | $1,636 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$27 | -$87 | $1,643 |
| Financing Cash Flow | $702 | $1,140 | $1,647 | $2,533 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$156 | $109 | -$406 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $156 | $47 | $453 | $457 |
| End Cash | $0 | $156 | $47 | $453 |
| Free Cash Flow | -$858 | -$1,031 | -$2,053 | -$2,537 |